[1]
|
Gao, K. and Wu, J. (2019) National Trend of Gastric Cancer Mortality in China (2003-2015): A Population-Based Study. Cancer Communications, 39, 1-5. https://doi.org/10.1186/s40880-019-0372-x
|
[2]
|
叶磊, 陈文. 紫杉醇腹腔灌注化疗治疗晚期胃癌合并恶性腹水的临床疗效观察[J]. 重庆医科大学学报, 2020, 45(9): 1279-1284.
|
[3]
|
Cunning-ham, D., Allum, W.H., Stenning, S.P., et al. (2006) Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. New England Journal of Medicine, 355, 11-20.
https://doi.org/10.1080/09502360600703419
|
[4]
|
Ychou, M., Boige, V., Pignon, J.P., et al. (2011) Perioperative Chemotherapy Compared with Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial. Journal of Clinical Oncology, 29, 1715-1721. https://doi.org/10.1200/JCO.2010.33.0597
|
[5]
|
D’Angelica, M., Gonen, M., Brennan, M.F., Turnbull, A.D., Bains, M. and Karpeh, M.S. (2004) Patterns of Initial Recurrence in Completely Resected Gastric Adenocarcinoma. Annals of Surgery, 240, 808-816.
https://doi.org/10.1097/01.sla.0000143245.28656.15
|
[6]
|
加雄, 郭亚焕, 曾述洪. 白蛋白结合型紫杉醇联合奥沙利铂、低剂量替吉奥治疗老年晚期贲门癌的效果及对肿瘤标志物、Hsp90α、CXCL4水平的影响[J]. 临床医学研究与实践, 2022, 7(27): 49-53.
|
[7]
|
钟文. PSOX方案在进展期胃癌新辅助化疗中有效性和临床安全性研究[D]: [硕士学位论文]. 西宁: 青海大学, 2021.
|
[8]
|
Wang, H.-Y., Yao, Z.-H., Tang, H., Zhao, Y., Zhang, X.-S., Yao, S.-N., et al. (2016) Weekly Nanoparticle Albumin-Bound Paclitaxel in Combination with Cisplatin Versus Weekly Sol-vent-Based Paclitaxel Plus Cisplatin as First-Line Therapy in Chinese Patients with Advanced Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy, 9, 5663-5669. https://doi.org/10.2147/OTT.S108580
|
[9]
|
Shitara, K., Ta-kashima, A., Fujitani, K., Koeda, K., Hara, H., Nakayama, N., et al. (2017) Nab-Paclitaxel versus Solvent-Based Paclitaxel in Patients with Previously Treated Advanced Gastric Cancer (ABSOLUTE): An Open-Label, Randomised, Non-Inferiority, Phase 3 Trial. The Lancet Gastroenterology and Hepatology, 2, 277-287.
https://doi.org/10.1016/S2468-1253(16)30219-9
|
[10]
|
Schiff, P.B. and Horwitz, S.B. (1980) Taxol Stabilizes Mi-crotubules in Mouse Fibroblast Cells. Proceedings of the National Academy of Sciences of the United States of America, 77, 1561-1565. https://doi.org/10.1073/pnas.77.3.1561
|
[11]
|
Verweij, J., Clavel, M. and Chevalier, B. (1994) Paclitaxel (Taxol) and Docetaxel (Taxotere): Not Simply Two of a Kind. Annals of Oncology, 5, 495-505. https://doi.org/10.1093/oxfordjournals.annonc.a058903
|
[12]
|
Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P. and Malik, A.B. (1997) Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Ki-nase-Dependent Pathway. Journal of Biological Chemistry, 272, 25968-25975. https://doi.org/10.1074/jbc.272.41.25968
|
[13]
|
Weiss, R.B., Donehower, R.C., Wiernik, P.H., Ohnuma, T., Gralla, R.J., Trump, D.L., Baker Jr., J.R., Van Echo, D.A., Von Hoff, D.D. and Leyland-Jones, B. (1990) Hypersensitivity Re-actions from Taxol. Journal of Clinical Oncology, 8, 1263-1268. https://doi.org/10.1200/JCO.1990.8.7.1263
|
[14]
|
Irizarry, L.D., Luu, T.H., McKoy, J.M., Samaras, A.T., Fisher, M.J., Carias, E.E., Raisch, D.W., Calhoun, E.A. and Bennett, C.L. (2009) Cremophor El-Containing Paclitaxel-Induced Anaphylaxis: A Call to Action. Community Oncology, 6, 132-134. https://doi.org/10.1016/S1548-5315(11)70224-8
|
[15]
|
Schnitzer, J.E. (1992) Gp60 Is an Albumin-Binding Glyco-protein Expressed by Continuous Endothelium Involved in Albumin Transcytosis. American Journal of Physiolo-gy-Heart and Circulatory Physiology, 262, H246-H254.
https://doi.org/10.1152/ajpheart.1992.262.1.H246
|
[16]
|
周际昌. 实用肿瘤内科学[M]. 第2版. 北京: 人民卫生出版社, 2003: 395-397.
|
[17]
|
Rixe, O., Ortuzar, W., Alvarez, M., et al. (1996) Oxaliplatin, Tetraplatin, Cisplatin, and Carboplatin: Spectrum of Activity in Drug-Resistant Cell Lines and in the Cell Lines of the National Cancer Institute’s Anticancer Drug Screen Panel. Biochemical Pharmacology, 52, 1855-1865. https://doi.org/10.1016/S0006-2952(97)81490-6
|
[18]
|
张建国, 郑国宝. 多西他赛联合替吉奥治疗晚期胃癌的疗效及作用机制分析[J]. 实用中西医结合临床, 2022, 22(15): 16-19.
|
[19]
|
缪敏, 丁倩, 蔡培培, 王磊. 周剂量白蛋白结合型紫杉醇联合SOX方案一线治疗晚期胃癌的临床观察[J]. 吉林医学, 2022, 43(11): 2982-2984.
|
[20]
|
刘子田, 王晓阳, 祝新, 等. 白蛋白结合型紫杉醇联合奥沙利铂和替吉奥在局部不可切除的进展期胃癌转化治疗中的应用[J]. 中国现代普通外科进展, 2021, 24(5): 374-377, 383.
|